Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYGlobal Sports Medicine Markets to 2024 – An $8.8 Billion Opportunity, Rising at a CAGR of 6%PREV STORYSurface Oncology Announces Filing of IND for CD39 Targeted Antibody Candidate, SRF617, at Inaugural R&D Day